Arsenic Trioxide

This publication has 9 references indexed in Scilit:

• Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
  Blood, 2001
• Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As2O3) on myeloma cells
  Leukemia Research, 2001
• Arsenicals in hematologic cancers.
  2000
• Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis.
  2000
• Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.
  2000
• Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
  1999
• The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms
  Leukemia, 1998
• Multiple myeloma: increasing evidence for a multistep transformation process.
  1998
• Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients
  Blood, 1997